Delta M+

Delta M+ Gamma Multi-frequency Light Therapy Technology

According to the R & D team of Delta and Clinical Trial team of Kaohsiung Medical University Hospital, the 40 Hz flickering light is easy to cause uncomfortable and eye pressure. The patients could not use that flickering light for more than 15 minutes


M +uses patented multi-frequency technology to reduce visible flickering and to ease uncomfortableness. A 40 Hz sharp-wave pattern has been confirmed on the digital light flicker analyzer by a third-party certification company (SGS Taiwan limited, New Taipei, Taiwan). According to the experimental results, in the cells irradiated with Delta multi-frequency technology, the expression quantity of the two phosphorylated proteins of Tau protein and mTOR protein was significantly reduced, indicating that the light source can inhibit their phosphorylation.


We presented Delta M+ excellent results of significantly reduce of Tau protein and mTOR protein on Alzheimer, at 2023 AD/ PD Conference, as Prof. Tsai’s finding which presented at 2021 AD/PD Conference. 


Again, we presented Delta M+ great finding of signifcant decrease in caregiver burden on BPSD (Behavioral and Psychological Symptoms of Dementia) at 2024 AD/PD Conference.

Delta M+ BrainCare light – Experimental results

  • SH-SY5Y cells are commonly used as an in vitro model of neuronal function and cell differentiation. It has been used to study many fields of neuroscience, including Parkinson's disease, Alzheimer's disease, neurotoxicity, ischemia or amyotrophic lateral sclerosis, and can even be used to study brain cellular and other features of neurogenesis.


  • In this experiment, Delta M+ composite frequency lamps were used to irradiate SH-SY5Y cells, and compared with cells that were not irradiated, to observe the changes of internal proteins.


  • The picture on the left shows the change of protein quantity observed by western blot test. Darker colors indicate higher amounts of protein, and lighter colors indicate lower amounts of protein.


  • According to the experimental results, in the cells irradiated with Delta multi-frequency technology , the expression quantity of the two phosphorylated proteins of Tau protein and mTOR protein were significantly reduced, indicating that the light source can inhibit their phosphorylation.


  • Tau protein and mTOR protein, two bad proteins, are considered to be the main cause of dementia if they accumulate.
  • Aβ40, Aβ42 and tau proteins in cerebrospinal fluid are considered to be potential pathogenesis of dementia Pathological indicators.
  • From the experimental results on the left, it can be concluded that the secretion of Aβ42 in SH-SY5Y cells is inhibited.

→ Aβ42 is a bad starch-like protein, which was significantly reduced after being exposed to M+ light.

The result of the upper part is to reduce the secretion of amyloid protein. In the pathological mechanism of dementia, the secretion of amyloid protein Aβ42 will increase. After the secretion is increased, these proteins will aggregate, and once aggregated, they will precipitate on the brain As long as pathological changes can be reduced, the two mechanisms of reduction and aggregation are good things for patients.

M+護智燈具 – 產品及論文發表

2022/08/13

國際阿茲海默病及相關病學術大會。【中國 北京】

臺灣高雄醫學大學楊淵韓教授講授阿爾茨海默病的精准處置。

2022/09/03

The Impact of COVID-19 on Cognition and Brain Health。【線上】

椿齡智研學會年度會議, 討論COVID-19 對認知和大腦健康的影響。

2022/09/25

第二屆失智症優良教案徵選頒獎典禮 暨 樂齡照護健康防疫研討會。【台灣 高雄】

中華護智協會主辦, 國衛院指導, 講述台達運用「光」技術在樂齡照護健康防疫的解決方案。

2022/09/30

高雄失智症個案管理師培訓課程 / 失智症及長期照護國際研討會。【台灣 高雄】

對應高齡社會，藉由活動促進產官學合作契機，探討精準醫療、整合性照護、智慧照護等新議題。

2022/12/01

2022 台灣醫療科技展。【台灣 台北】

台達攤位上展覽護智燈，並獲得醫療機構合作機會：中山醫學大學。

高醫專題演講：阿茲海默失智症的篩檢及病程預測。

2022/12/19

新加玻佛光山醫學講座。【新加玻】

中華護智協會理事長楊淵韓教授講授伽馬震盪對老化和失智的影響，並發表台達產品測試結果。

2022/12/22

佛光山曼谷文教中心護智醫學講座。【泰國 曼谷】

中華護智協會理事長楊淵韓教授講授老化及伽馬震盪相關議題，並發表台達產品測試結果。

2023/03/28

AD/PD 2023 Advances in Science & Therapy。【瑞典 哥特堡】(Accepted, 相關領域最具規模之國際研討會)

老年癡呆和帕金森氏病相關的大型國際會議，將發表台達M+產品相關成果。

國際期刊論文

Journal of Alzheimer's Disease 。【投稿中】